1

2
Jon Hangeland, Minsheng Zhang, Yolanda Caringal, Denis Ryono, Yi Lin Li, Johan Malm, Ye Liu, Neeraj Garg, Chris Litten, Ana Maria Garcia Collazo, Konrad Koehler: Thyroid receptor ligands and method II. Karo Bio, Todd E Garabedian, Wiggin and Dana, January 24, 2006: US06989402 (16 worldwide citation)

New thyroid receptor ligands are provided which have general formula (I) in which: n is an integer from 0 to 4; R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or different and are hydrogen, halogen, alkyl of 1 to 4 carbons or cycloa ...


3

4
Jon Hangeland, Minsheng Zhang, Yolanda Caringal, Denis Ryono, Yi Lin Li, Johan Malm, Ye Liu, Neeraj Garg, Chris Litten, Ana Maria Garcia Collazo, Konrad Koehler: Thyroid receptor ligands and method II. Karo Bio, Wiggin and Dana, Todd E Garabedian, Elizabeth A Galletta, October 30, 2007: US07288571 (3 worldwide citation)

New thyroid receptor ligands are provided which have general formula (I) in which: n is an integer from 0 to 4; R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or different and are hydrogen, halogen, alkyl of 1 to 4 carbons or cycloa ...


5

6
Jon Hangeland, Zhang Minsheng, Yolanda Caringal: New thryoid receptor ligands and process ii. Karo Bio, wen qi, February 27, 2002: CN99815057

New thyroid receptor ligands are provided which have general formula (I) in which: n is an integer from 0 to 4; R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or different and are hydrogen, halogen, alkyl of 1 to 4 carbons or cycloa ...


7
Minsheng Zhang, Jon Hangeland, Yolanda Caringal, Todd Friends: Pyridine-based thyroid receptor ligands. Stephen B Davis, Bristol Myers Squibb Company, February 26, 2004: US20040039028-A1

Novel pyridine-based thyroid receptor ligands are provided which have the general formula I 1 wherein: X is oxygen (—O—), sulfur (—S—), sulfoxide (—S(O)—), sulfonyl (—SO2—), CR8R8 or NR8; Y is —NR8, oxygen (—O—), —CH2— or sulfur (—S—); Z is a bond or substituted or unsubstituted C1-4 alkyl; and wher ...


8
Jill E Wood, Hanno Wild, Daniel H Rogers, John Lyons, Michael Katz, Yolanda Caringal, Robert Dally, Wendy Lee, Roger A Smith, Cheri Blum: Raf kinase inhibitors. Millen White Zelano & Branigan PC, November 17, 2005: US20050256174-A1

Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.


9
Jon Hangeland, Minsheng Zhang, Yolanda Caringal, Denis Ryono, Yi Lin Li, Johan Malm, Ye Liu, Neeraj Garg, Chris Litten, Ana Maria Garcia Collazo, Konrad Koehler: Novel thyroid receptor ligands and method II. Wiggin And Dana, December 22, 2005: US20050282872-A1

New thyroid receptor ligands are provided which have general formula (I) in which: n is an integer from 0 to 4; R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or differential hydrogen, halogen, alkyl of 1 to 4 carbons or cycloalkyl ...


10
Jill E WOOD, Hanno Wild, Daniel H Rogers, John Lyons, Michael Katz, Yolanda Caringal, Robert Dally, Wendy Lee, Roger A Smith, Cheri Blum: Raf Kinase Inhibitors. Millen White Zelano & Branigan PC, March 11, 2010: US20100063088-A1

Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.